EZH2 and plasma cell myeloma: There are extensive data demonstrating the essential role of EZH2 in the incidence of multiple human malignancies such as multiple myeloma, lymphoma, melanoma, thyroid, prostate, breast, bladder, and liver cancers [7–9].